Stockreport

Better Buy: Cara Therapeutics vs. Sangamo Therapeutics [The Motley Fool]

Cara Therapeutics, Inc.  (CARA) 
Last cara therapeutics, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.caratherapeutics.com/investor-relations
PDF You can't lump all clinical-stage biotechs together. TakeCara Therapeutics(NASDAQ:CARASangamo TherapeuticsNASDAQ:SGMOInvestors have placed a greater value on Sangamo's p [Read more]